RNF144B
Basic information
Region (hg38): 6:18387350-18468870
Previous symbols: [ "IBRDC2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RNF144B gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 16 | 18 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 16 | 2 | 0 |
Variants in RNF144B
This is a list of pathogenic ClinVar variants found in the RNF144B region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-18399560-A-G | not specified | Likely benign (Oct 14, 2023) | ||
6-18399578-A-G | not specified | Uncertain significance (Oct 18, 2021) | ||
6-18399583-C-T | not specified | Uncertain significance (Oct 20, 2021) | ||
6-18399605-C-T | not specified | Likely benign (Dec 19, 2022) | ||
6-18399626-A-C | not specified | Uncertain significance (Oct 26, 2022) | ||
6-18399658-A-G | not specified | Uncertain significance (Jan 09, 2024) | ||
6-18399682-T-G | not specified | Uncertain significance (Sep 08, 2024) | ||
6-18399683-G-A | not specified | Uncertain significance (May 08, 2023) | ||
6-18427623-G-C | not specified | Uncertain significance (Jun 02, 2023) | ||
6-18427636-C-T | not specified | Uncertain significance (Apr 13, 2022) | ||
6-18457163-C-G | not specified | Uncertain significance (May 05, 2023) | ||
6-18457170-C-A | not specified | Uncertain significance (Jul 30, 2024) | ||
6-18457173-A-G | not specified | Uncertain significance (Nov 07, 2022) | ||
6-18457176-G-A | not specified | Uncertain significance (May 18, 2023) | ||
6-18457313-G-A | not specified | Uncertain significance (May 01, 2024) | ||
6-18457316-T-C | not specified | Uncertain significance (Feb 15, 2023) | ||
6-18459615-T-C | not specified | Uncertain significance (Jul 14, 2024) | ||
6-18459632-G-A | not specified | Uncertain significance (Jun 17, 2024) | ||
6-18459660-G-A | not specified | Uncertain significance (Nov 15, 2024) | ||
6-18459674-C-T | not specified | Uncertain significance (Jun 28, 2022) | ||
6-18459708-A-C | not specified | Uncertain significance (Nov 26, 2024) | ||
6-18459717-A-G | not specified | Uncertain significance (Aug 11, 2024) | ||
6-18459720-C-T | not specified | Uncertain significance (Dec 01, 2022) | ||
6-18463334-A-G | not specified | Uncertain significance (May 27, 2022) | ||
6-18463355-C-A | not specified | Uncertain significance (May 01, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RNF144B | protein_coding | protein_coding | ENST00000259939 | 7 | 100327 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
6.35e-10 | 0.241 | 125713 | 0 | 35 | 125748 | 0.000139 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.531 | 151 | 171 | 0.886 | 0.00000877 | 1975 |
Missense in Polyphen | 43 | 52.611 | 0.81731 | 622 | ||
Synonymous | -0.270 | 67 | 64.2 | 1.04 | 0.00000340 | 585 |
Loss of Function | 0.692 | 16 | 19.3 | 0.830 | 0.00000116 | 196 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000326 | 0.000326 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000272 | 0.000272 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000150 | 0.000149 |
Middle Eastern | 0.000272 | 0.000272 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from E2 ubiquitin-conjugating enzymes UBE2L3 and UBE2L6 in the form of a thioester and then directly transfers the ubiquitin to targeted substrates such as LCMT2, thereby promoting their degradation. Induces apoptosis via a p53/TP53-dependent but caspase-independent mechanism. However, its overexpression also produces a decrease of the ubiquitin-dependent stability of BAX, a pro-apoptotic protein, ultimately leading to protection of cell death; But, it is not an anti-apoptotic protein per se. {ECO:0000269|PubMed:12853982, ECO:0000269|PubMed:20300062}.;
- Pathway
- Gastric Cancer Network 2;Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Direct p53 effectors
(Consensus)
Recessive Scores
- pRec
- 0.117
Intolerance Scores
- loftool
- 0.644
- rvis_EVS
- 0.06
- rvis_percentile_EVS
- 58.53
Haploinsufficiency Scores
- pHI
- 0.242
- hipred
- Y
- hipred_score
- 0.540
- ghis
- 0.469
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.879
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rnf144b
- Phenotype
- cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hearing/vestibular/ear phenotype; vision/eye phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- protein polyubiquitination;ubiquitin-dependent protein catabolic process;apoptotic process;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;negative regulation of apoptotic process
- Cellular component
- ubiquitin ligase complex;cytoplasm;cytosol;integral component of membrane;mitochondrial membrane
- Molecular function
- ubiquitin-protein transferase activity;protein binding;ubiquitin conjugating enzyme binding;metal ion binding;ubiquitin protein ligase activity